Variable | Frequency (n, %) | Median OS (95% CI) (months) | P-value |
ACE rate |
|
| 0.606 |
<5 | 10 (52.63%) | 42 (13.182 - 70.818) |
|
≥5 | 9 (47.37%) | 38 (0.000 - 82.350) |
|
Hemoglobin (g/dl) |
|
| 0.840 |
<12 | 45 (81.82%) | 43 (377.144 - 48.856) |
|
≥12 | 10 (18.18%) | 45 (15.045 - 74.955) |
|
Depth of Tumour Invasion |
|
| 0.205 |
T1/2 | 24 (38.09%) | - |
|
T3 | 21 (33.33%) | 28 (31.828 - 58.380) |
|
T4 | 18 (28.57%) | 42 (6.891 - 26.173) |
|
Lymph node involvement |
|
| 0.112 |
N1 | 10 (19.23%) | - |
|
N2 | 27 (51.92%) | 43 (27.800 - 41.501) |
|
N3 | 15 (28.85%) | 42 (23.100 - 56.766) |
|
Lymph Node Metastasis |
|
| 0.041 |
Yes | 42 | 42 (27.254 - 56.646) |
|
No | 10 | - |
|
Distant Metastasis |
|
| <0.001 |
M0 | 51 (75.00%) | - |
|
M1 | 17 (25.00%) | 24 (5.749 - 42.251) |
|